[Tree] ALS drug failure, positive results in narcolepsy treatment, and Axsome's phase 3 trial for binge eating disorder drug

Version 0.12 (2024-04-01 19:23:15.096000)

updates: Axsome initiates phase 3 trial for solriamfetol in binge eating disorder

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.11 (2024-03-26 13:24:01.426000)

updates: Citi increases Axsome Therapeutics stock target after positive Phase 3 narcolepsy data

  • ➔
  • ➔
  • ➔
Version 0.1 (2024-03-25 11:22:53.128000)

updates: Positive results from Phase 3 trial of AXS-12 in narcolepsy treatment

  • ➔
  • ➔
Version 0.09 (2024-03-09 06:27:27.905000)

updates: ALS drug Relyvrio fails in Phase III trial

  • ➔
Version 0.08 (2024-03-04 22:10:33.660000)

updates: New data on Biogen's Alzheimer's disease portfolio at AD/PD 2024 Annual Meeting

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.08 (2024-03-04 22:10:33.660000)

updates: New data on Biogen's Alzheimer's disease portfolio at AD/PD 2024 Annual Meeting

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.08 (2024-03-04 22:10:33.660000)

updates: New data on Biogen's Alzheimer's disease portfolio at AD/PD 2024 Annual Meeting

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.07 (2024-02-28 18:37:01.446000)

updates: New information on positive preclinical study for TGR-63 in Alzheimer's treatment

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.07 (2024-02-28 18:37:01.446000)

updates: New information on positive preclinical study for TGR-63 in Alzheimer's treatment

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-02-26 19:59:04.832000)

updates: Aprinoia Therapeutics files for IPO to advance neurodegenerative disease treatment

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-02-22 14:04:42.317000)

updates: Introduction of a groundbreaking OSA therapy at a biotech conference

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-02-21 12:47:04.015000)

updates: Introduction of Absci Corporation's IND-enabling studies for ABS-101

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2024-02-20 20:02:54.585000)

updates: The launch of Alzheimer's drug Leqembi is off to a slow start

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2024-02-19 10:29:44.042000)

updates: Collaboration between InveniAI and Ono Pharmaceutical for target discovery

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-12-22 04:07:37.541000)

updates: Collaboration agreement between Ono and EVQLV for antibody drug development

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-11-27 13:48:33.426000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔